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ABSTRACT 
 
It has been hypothesized that flavonoids in foods and beverages may reduce cancer risk through 
antioxidation, inhibition of inflammation, and other antimutagenic and antiproliferative 
properties. We examined associations between intake of five flavonoid subclasses 
(anthocyanidins, flavan-3-ols, flavones, flavonols, flavanones) and lung cancer risk in a 
population-based case-control study in Montreal, Canada (1,061 cases and 1,425 controls). 
Flavonoid intake was estimated from a food frequency questionnaire that assessed diet two years 
prior to diagnosis (cases) or interview (controls). Odds ratios (ORs) and 95% confidence 
intervals (CIs) were estimated using unconditional logistic regression. Overall, total flavonoid 
intake was not associated with lung cancer risk, the effect being similar regardless of sex and 
smoking level. However, low flavonoid intake from food, but not from beverages, was 
associated with an increased risk. The adjusted ORs (95% CIs) comparing the highest versus the 
lowest quartiles of intake were 0.63 (0.47-0.85) for total flavonoids, 0.82 (0.61-1.11) for 
anthocyanidins, 0.67 (0.50-0.90) for flavan-3-ols, 0.68 (0.50-0.93) for flavones, 0.62 (0.45-0.84) 
for flavonols, and 0.70 (0.53-0.94) for flavanones. An inverse association with total flavone and 
flavanone intake was observed for squamous cell carcinoma but not adenocarcinoma. In 
conclusion, low flavonoid intake from food may increase lung cancer risk. 
 
Keyword: lung cancer, diet, flavonoids, case-control study, epidemiological 
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INTRODUCTION 
Between 80-90% of lung cancers are attributable to smoking in North American populations (1),  
however, it is clear that other factors influence risk as lung cancer also occurs among individuals 
who have never smoked (2). Furthermore, not all smokers (about 15%) eventually develop lung 
cancer (3), suggesting that other factors may modify the risk associated with tobacco 
carcinogens.  Flavonoids are a family of polyphenols abundant in fruits, vegetables, and some 
beverages including tea, beer, and wine.  There are about 8,000 individual flavonoid compounds 
in foods, which are categorized in six major subclasses: flavonols, flavones, flavanones, flavan-
3-ols (also referred to as catechins), anthocyanidins, and isoflavones (4). Flavonoids have 
multiple biological properties that may contribute to the lower lung cancer risk often associated 
with fruits and vegetables, including antioxidant activity, inflammation inhibition, as well as 
other antimutagenic and antiproliferative properties (5, 6). Although findings have been 
somewhat inconsistent, there is evidence from animal studies that dietary flavonoids can be 
found in lung tissue and thus may exert a role in cancer prevention (7-9).  
 
Among previous studies that have examined flavonoid intake in relation to lung cancer, several 
have reported statistically significant risk reductions of 17-76% for the highest versus lowest 
intakes of the flavonol, flavone and flavan-3-ol subclasses (10-17).  However, other studies have 
reported no association (18-24), or a risk reduction only among smokers (10, 21). These 
differences may be due to differing sources (i.e. food or beverage) and types of flavonoids 
measured, or different distributions of other lung cancer determinants (i.e. smoking). Another 
possible reason for inconsistencies is that until recently, existing food composition databases 
included only a limited number of flavonoid compounds and flavonoid- containing foods (25, 
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26). Thus, although many past studies examined flavonols and flavones, few have examined 
flavan-3-ols (10, 16, 19-21, 23), flavanones (10, 14-16, 21-23), and anthocyanidins (16). In 2003 
the US Department of Agriculture (USDA) produced a comprehensive food composition 
database for flavonoids that includes over 250 foods and 19 different flavonoid compounds 
among five subclasses (27).  The USDA database, updated in 2007 (28), uses high quality 
control. 
 
In the context of a population-based case-control study of lung cancer carried out in Montreal, 
Canada, information was collected on a number of personal, lifestyle and environmental factors, 
including diet. We used these data to examine the association between flavonoid intake and lung 
cancer risk among men and women.  
 
MATERIALS AND METHODS 
Study population 
This study, described in detail elsewhere (29), included male and female Canadians aged 35 to 
75 years old who resided in the greater Montreal area. Newly diagnosed lung cancer cases 
occurring between January 1996 and December 1997 were identified at 18 hospitals, capturing 
over 98% of diagnoses in the study base. Overall, 1,429 men and women with histologically 
confirmed incident lung cancer were eligible and 84% (n=738 men, 465 women) participated. 
Interviews were conducted an average of 12.1 months after diagnosis. If a participant had died 
before the interview or was too ill, the interview was conducted with the next of kin. Histological 
type was confirmed by pathology reports (30).  The sampling frame used to select population 
controls was the Provincial Electoral List. Population controls were randomly selected, stratified 
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to the expected age (± 5 years) and sex distribution of cases. Among 2,179 potential controls that 
were approached, 69% (n=899 men, 614 women) participated.  After excluding persons with 
incomplete food frequency questionnaire (FFQ) information (>50% of FFQ items missing; 
n=162), extreme energy intakes (i.e. >3 standard deviations [SD] from the log-transformed mean 
total energy intake; n=27), extreme alcohol intakes (upper 1% [i.e. reporting >24 drinks daily]; 
n=8) and missing smoking data (n=33), 2486 persons remained (1,061 cases and 1,425 controls). 
Written informed consent was obtained from participants, and the study was approved by the 
Institutional Review Boards of all the participating Universities and hospitals. 
 
Data collection and assessment of flavonoids 
In-person interviews were conducted to assess socio-demographic and lifestyle characteristics 
(including smoking, diet and beverage intake) and detailed occupational history (31).  Diet from 
two years prior to diagnosis (cases) or interview (controls) was assessed using a semiquantitative 
FFQ developed by the Canadian Cancer Registries Epidemiology Research Group (32), with 
modifications to reflect the diet of our study population, to capture major sources of carotenoids 
and vitamin C, and to abbreviate questionnaire length.  The FFQ included 42 items, including 77 
fruits, vegetables, meats, dairy products and grain products. Participants reported their usual 
frequency of consumption of a typical portion in categories of: 7+ times/week, 4-6 times/week, 
1-3 times/week, 1-3 times/month, or never or <1 time/month.  Participants also reported whether 
they consumed coffee, tea and alcohol (i.e. wine, beer and spirits) regularly, and if so, their 
average daily consumption.  Consistent with the FFQ data, beverage consumption 2 years prior 
to interview was used. Portion sizes were converted into grams using Health Canada’s Canadian 
Nutrient File (33).  Daily intake of each food in grams per day (g/day) was calculated by 
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multiplying participants’ reported frequency of intake of the typical portion (in days) by the 
number of grams in that portion. 
   
Intake indices were computed for the following five flavonoid subclasses (with example high 
contributors from our specific FFQ): anthocyanidins (berries, red wine), flavan-3-ols (tea, red 
wine), flavones (red wine, citrus fruit), flavonols (apples, pears, tea), and flavanones (citrus 
fruit). Isoflavone intake was not analyzed because tofu, other soy products and other isoflavone-
rich foods, such as chickpeas and peanuts (34) were not on the FFQ.  Flavonoid content in foods 
and beverages was determined using the most recent 2007 USDA database (28).  For each 
food/beverage, the specific flavonoid compound value in milligrams per 100 grams of 
food/beverage was extracted from the USDA database.  For grouped food items, a weighted 
average of flavonoid content was calculated (35),  where weights were based on average per 
capita consumption of each food (36). Red versus white wine consumption was weighted 
according to recent consumption statistics (37) and tea intake was assumed to be only black tea 
based on local habits before the 1990s. Since flavonoid content can vary according to the form of 
the food (e.g. fresh, canned or frozen), we further weighted flavonoid values according to the 
relative consumption of the different forms (36).  Since cooking can change flavonoid content, 
we used data from an FFQ validation study in Montreal conducted during the same time period 
(38) to weight flavonoid content values for some vegetables (asparagus, broccoli, carrots, 
cabbage, cauliflower, Brussels sprouts, spinach, peas, corn and tomatoes) according to raw 
versus cooked.  
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Daily consumption of each flavonoid subclass was calculated by multiplying the flavonoid 
content for each food/beverage by the frequency of intake (in grams per day) of that item.  Total 
flavonoid intake was calculated as the summed total of each of the flavonoid subclasses. 
Flavonoid intake was adjusted for total energy using the residual method (39).     
 
Statistical analysis 
Total flavonoid intake and total intake of each of the five flavonoid subclasses were analyzed in 
separate multivariable models. Unconditional logistic regression was used to estimate odds ratios 
(ORs) and associated 95% confidence intervals (CIs).  Flavonoid intake was analyzed as 
categorical variables, where intake was divided into sex-specific quartiles based on the 
distribution among controls.  
 
In multivariable models, associations were adjusted for age at diagnosis/interview (continuous), 
sex, respondent status (self, proxy), ethnic origin (French Canadian, other), education (<7 years, 
7-12 years, ≥12 years), mean census tract family income (low, medium, high), alcohol intake 
(continuous, drinks/day), body mass index (BMI, kg/m2; underweight [<18.5], normal [18.5-
24.9], overweight [25-29.9], obese [≥30]), total energy intake (continuous, kilocalories/day), 
occupational exposure to major lung carcinogens (ever exposure to asbestos, arsenic/arsenic 
compounds, beryllium, silica,  cadmium, chromium, and/or nickel compounds), and cigarette 
smoking.  These variables were selected a priori, based only on the following criteria: they were 
known to be associated with lung cancer and they were available in our database.  Further, these 
variables were associated with flavonoid intake in this study population (data not shown), and 
are unlikely to lie on the causal pathway between exposure (flavonoid intake) and outcome (lung 
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cancer).  Cigarette smoking was modeled using the comprehensive smoking index (CSI), which 
is a continuous variable that aggregates information on smoking status (ever, never), duration 
and smoking intensity (pack-years), and for former smokers, the number of years since quitting 
smoking, in a single measure (40). This index has been successfully used to parameterize 
smoking history in this population (40).  
 
Modification of the ORs by sex and smoking was evaluated by including product terms for the 
flavonoid variable and the effect modifier of interest. The p-value for multiplicative interaction 
was based on the likelihood ratio test comparing models with and without the product terms. 
Smoking level was dichotomized as light-smokers and moderate/heavy-smokers based on the 
distribution of the CSI among ever smokers. Never-smokers (n=47 cases, n=445 controls) were 
combined with light-smokers, defined as persons in the lowest quartile of the CSI among ever 
smokers. We acknowledge that this category includes some participants with a nontrivial risk of 
lung cancer due to smoking; the OR (95% CI) comparing light to never smokers was 2.00 (1.37-
2.93).  However, the number of cases that never smoked is too small to support separate 
analyses. The OR (95% CI) comparing the moderate/heavy smokers with the combined 
never/light smoker group is 10.41 (8.44-12.84), showing that these are meaningfully different 
groups with respect to smoking, and therefore informative to assess effect modification. 
 
Because beverage intake was assessed on a questionnaire separate from the FFQ and since 
polyphenols may be absorbed differently from different foods and beverages (41), we performed 
separate analyses for flavonoids from food versus beverage sources (i.e. tea, wine, beer). 
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We also examined associations by lung cancer histology (adenocarcinoma, squamous cell 
carcinoma, and small cell carcinoma) using polytomous logistic regression. To test if the 
associations between quartiles of flavonoid intake and lung cancer risk differed by histology, we 
fit one model, where for each quartile of the flavonoid distribution, we estimated separate 
regression coefficients for each of the three histologic types, and then a second model using the 
same data, where we forced the three corresponding regression coefficients for a given quartile 
to have the same value regardless of the histologic subtype. We then used a 6-degree-of-freedom 
likelihood ratio test of homogeneity to test if the first model fit the polytomous data significantly 
better than the second, restricted model. All statistical tests were two-sided and a p-value of less 
than 0.05 was considered to be statistically significant. All analyses were performed using 
STATA version 8. 
 
RESULTS 
The study population is described in table 1.  For men, the mean age was 64.2 years (SD=7.8) for 
cases and 64.9 (SD=7.6) for controls; for women the mean age was 61.4 (SD=9.4) for cases and 
61.4 (SD=9.3) for controls.  Approximately 1/3 of interviews among cases were completed by 
proxy, usually the spouse, compared with fewer than 10% among controls.  A higher proportion 
of cases reported French ancestry, and cases were more likely to have lower family income and 
fewer years of schooling.  As expected, a higher proportion of cases were former or current 
smokers.  The majority of lung cancers were adenocarcinoma or squamous cell carcinoma.   
 
The median (interquartile range) of total flavonoid intake, calculated by summing intake of all 
five subclasses was 108.8 (53.7- 434.2) mg/day for cases and 117.7 (69.6-340.6) mg/day for 
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controls.  Intake of flavonoid subclasses was similar to previous studies that used the USDA 
flavonoids database (10, 16, 21, 23). Table 2 shows the food and beverage items that contributed 
most to each of the flavonoid subclasses in our study population. Intake of black tea was the 
largest contributor to total flavonoid intake. 
 
Pairwise linear Pearson correlation coefficients (r) between total intake of each of the flavonoid 
subclasses ranged from the absence of any correlation (r=-0.08) between flavones and flavan-3-
ols to near-collinearity (r=0.94) between flavonols and flavan-3-ols. There was moderately high 
correlation between vitamin C and total flavone (r=0.45) and flavanone (r=0.54) intake, as well 
as between the carotenoid beta-cryptoxanthin and these same flavonoid classes (r=0.47 and 
0.51).   
 
Table 3 shows both crude and adjusted ORs of lung cancer for each quartile of intake, relative to 
the lowest quartile, for each of the five flavonoid subclasses and for all flavonoids combined. 
While most of the crude ORs were statistically significantly below 1.00, in multivariable models 
the ORs were attenuated and a statistically significant inverse association for the highest versus 
lowest intake was observed only for flavones and flavanones. For anthocyandins and flavonols, a 
statistically significant relative risk below 1.00 was observed in the third versus the first quartile, 
while for total flavonoids a statistically significant inverse association was observed in the 
second quartile. Smoking was the covariate whose inclusion in the model resulted in the greatest 
attenuation of the ORs for all flavonoid variables (>10% change in OR). When analyses were 
conducted using the standard multivariable approach to adjust for total energy intake, rather than 
the residual method, results were similar (not shown).  
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For each of the flavonoid subclasses, there was no evidence of statistically significant effect 
modification by sex (table 4), except for anthocyandins, where an inverse association was more 
apparent among females. Similarly, there was no statistically significant effect modification by 
smoking level (table 4), though the ORs in the third quartile of intake of total flavonoids, flavan-
3-ols, and flavonols suggested increased risks among never-light smokers and reduced risks 
among moderate-heavy smokers.  
 
When considering flavonoids from beverage sources only there was no evidence of an 
association for any of the six flavonoid variables. In contrast, for flavonoids from food sources, 
statistically significant inverse associations were observed for all flavonoids except for 
anthocyanidins (table 5). Because of the high contribution of tea to some flavonoid groups, in a 
sensitivity analysis, we calculated intake of each flavonoid without the contribution of tea and 
observed results similar to the results that considered food sources only, with the ORs decreasing 
monotonically with increasing quartiles of flavonoid intake. The adjusted ORs (95% CI) 
systematically indicated risk reductions for the highest versus lowest quartiles of flavonoid 
intake from non-tea sources, and were 0.63 (0.46-0.84) for total flavonoids, 0.86 (0.64-1.15) for 
anthocyanidins, 0.57 (0.42-0.77) for flavan-3-ols, 0.68 (0.51-0.92) for flavones, 0.54 (0.40-0.73) 
for flavonols, and 0.71 (0.53-0.95) for flavanones). 
 
For most of the flavonoid variables, the pattern of ORs across the four quartiles of total intake 
did not vary significantly across the different histological types (table 6), except for flavones and 
flavanones. For flavones, the risk of squamous cell carcinoma was significantly reduced for all 
three higher quartiles of intake relative to the lowest intake, while associations were closer to the 
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null for small cell carcinoma and adenocarcinoma. Similarly, flavanone intake was inversely 
associated with squamous cell carcinoma, but not with adenocarcinoma or small cell carcinoma. 
However, for flavanones, the heterogeneity of the associations were statistically non-significant 
when applying the Bonferroni-corrected significance level of 0.008 to account for an inflated risk 
of type I error due to multiple testing (i.e. a total of 6 tests for the 6 difference flavonoid 
variables). Given the findings observed in Table 5, we also analyzed flavonoids from food 
sources only for each of the histological types. The findings were similar to that observed for 
flavonoids from all sources, except for total flavonoid intake where a statistically significant 
difference between histological types was observed, reflecting a significant inverse association 
with squamous cell carcinoma but not adenocarcinoma or small cell carcinoma (Table 6).  
 
In sensitivity analyses to assess the potential for information bias by respondent status (proxy 
versus self), we restricted analyses to self-respondents only. The pattern of association across 
quartiles was the same for all 6 flavonoid variables; the adjusted ORs (95% CIs) for the highest 
versus the lowest quartiles were 0.84 (0.61-1.15) for anthocyanidin intake, 1.03 (0.77-1.39) for 
flavan-3-ol intake, 0.65 (0.47-0.89) for flavone intake, 0.97 (0.72-1.30) for flavonol intake, 0.69 
(0.50-0.95) for flavanone intake, and 0.94 (0.72-1.22) for total flavonoid intake. We also 
conducted analyses where smoking was adjusted for more conventionally using the three 
variables of smoking status (ever smoker, never smoker), cigarette-years, and time since quitting 
(in years), rather than the CSI, and the results were not appreciably different (results not shown).  
Because our FFQ was specifically designed to capture foods rich in carotenoids and vitamin C, 
which are correlated with flavonoids in food, we further evaluated the potential confounding 
effect of total carotenoid intake and vitamin C intake. Adjusting for total carotenoid intake did 
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not substantially affect the results (not shown).  However, after adjusting for vitamin C intake, 
the inverse associations with flavones and flavanones were attenuated. The adjusted OR (95% 
CI) for the highest versus the lowest quartiles of intake was 0.76 (0.54-1.06) for flavone intake 
and 0.79 (0.54-1.16) for flavanone intake.  In these models, the association between vitamin C 
intake and lung cancer risk was also attenuated (data not shown).   
 
DISCUSSION 
Using data from a large, population-based case-control study, we observed that low intake of 
flavonoids from foods, but not from beverages, was associated with a higher risk of lung cancer 
overall. There was some suggestion that the inverse association with flavonoids, particularly for 
flavones and flavanones, was greater for squamous cell carcinoma than for adenocarcinoma or 
small cell carcinoma. Our results suggest that low flavonoid intake from food sources may 
increase risk of lung cancer, particularly for squamous cell carcinoma. 
 
Previous studies have provided mixed evidence for a possible inverse association between 
dietary flavonoid intake and lung cancer. However, most studies used food composition 
databases that were more limited than the recent USDA database.  Of the studies that did not use 
the recent USDA database for flavonoids, findings have been about evenly split between an 
inverse association (11-15) and no association (17-20, 22, 24). Among studies using the recent 
2003 USDA database, Lagiou et al reported an increased lung cancer risk with increased 
flavonol intake, and no association with either flavanones or flavan-3-ols (23).  In contrast, a 
Finnish cohort study reported a strong inverse association with increased intakes of flavonols and 
flavan-3-ols, though no association for the remaining 3 subclasses (16).  Of the two previous 
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North American studies, one prospective study reported reduced lung cancer risks of 32% with 
flavanone intake (21), while in another case-control study, intake of flavan-3-ols, as well as 
quercetin and kaempferol, which are both flavonols, were associated with risk reductions of 32% 
to 51%, particularly among smokers (10). 
 
As in the two recent North American studies that used the 2003 USDA database, we observed 
reduced lung cancer risks associated with increasing intake of certain flavonoid subclasses.  On 
the other hand, the associations we observed for flavonols, flavan-3-ols and total flavonoids were 
non-monotonic; using the lowest intake quartile as the reference, the relative risk dipped in the 
middle range of intake and then increased in the highest intake quartile to reach levels similar to 
the lowest quartile. We further observed that the pattern of associations differed between 
flavonoids from food versus beverage sources. These various findings are compatible with the 
hypothesis that another component in flavonoid-rich foods (not present in beverages) is 
responsible for these inverse associations among food source flavonoids. For instance, we found 
that associations were attenuated when vitamin C was included as a covariate in the analyses. In 
two previous studies that included vitamin C in their models, an association with flavonoids was 
not observed (18, 19). Our study was not large enough to tease out the potential relative 
contributions of intercorrelated measures of flavonoids and vitamin C intake. 
 
Alternatively, the differences between food and beverage sources may reflect the effects of other 
non-flavonoid nutrients found in wine, beer and tea, such as alcohol in wine and beer, or caffeine 
in tea, that may increase lung cancer risk. The non-monotonic relationship between lung cancer 
and intake of flavan-3-ols, flavonols and total flavonoids may reflect the balance between the 
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possible protective effect of flavonoids and the potential carcinogenic effects of other components 
of beverages (i.e. alcohol, caffeine), particularly at high intakes. Indeed, there is some evidence 
that high alcohol intake increases lung cancer risk in our study population (29). Black tea, which 
contributes heavily to flavan-3-ols and flavonols, has been associated both positively and 
negatively with lung cancer (42). Caffeine is a nutrient present in tea, but not in beer or wine, that 
may contribute to an increased risk, though there is currently little evidence for the carcinogenicity 
of caffeine (43). Variation in tea brewing time up to 5 minutes may influence flavonoid content 
(44). In addition, the main flavan-3-ols in tea [(-)-epigallocatechin gallate and (-)-epicatechin 
gallate] differ from the main flavan-3-ols found in foods [(+)-catechin and (-)-epicatechin], which 
may have contributed to the observed differences between foods and beverages. Furthermore, the 
differences may reflect variations in bioavailability or metabolism of the flavonoids in solid foods 
versus liquid beverages (45). On the other hand, these differences may reflect residual 
confounding, uncontrolled confounding by an unmeasured factor or possibly differential 
measurement error in determining intakes of beverages versus foods. 
    
With 1,061 cases and 1,425 controls, this study represents the largest study examining flavonoid 
intake and lung cancer risk using the recent USDA food composition database. This sample size 
allowed us to examine potential effect modification by sex and smoking and to conduct separate 
analyses by histological type. We did not find statistically significant evidence of effect 
modification by smoking level, though reduced risks in the middle quartiles of intake of total 
flavonoids, flavan-3-ols and flavonols were more apparent among moderate-heavy smokers 
compared to never-light smokers.  Among previous studies that have examined the potential 
modifying effect of smoking, most (10, 21, 22), but not all (46), have observed a stronger inverse 
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association among heavy smokers. It has been suggested that a stronger protective effect among 
smokers may be due to the biological mechanism of flavonoids, which may have strong 
antioxidant activity against the oxidative stress that results from smoking (10, 21). Only one 
other study presented results according to histology (22), and similar to our findings, they 
observed that inverse associations were stronger for squamous cell carcinoma and other 
histologies combined, compared to adenocarcinomas. Given that adenocarcinoma is the 
histological type that is most weakly associated with smoking (2), this observation may reflect 
that flavonoids play more of a protective role among those cancers more strongly associated with 
smoking.   
 
Cases and controls were selected from the same study base, representing Canadian citizens 
residing in the greater Montreal area, and participation rates were relatively high, even among 
controls (70%). Nonetheless, it is possible that participating controls were not representative of 
all eligible controls with respect to diet. Differential reporting of diet by cases and controls may 
also have produced a bias in our results, as in any case-control study. There is undoubtedly some 
degree of misclassification in any attempt to measure nutrient intake on the basis of a FFQ, 
including ours. Such error would likely be non-differential with respect to case-control status, 
and thus, would have attenuated the strength of any true associations. Using proxy respondents 
for some participants may also have resulted in exposure misclassification, although our results 
were almost identical when restricted to self-respondents.  
 
A major concern in epidemiological studies of lung cancer is the potential for residual 
confounding by smoking. For instance, it is possible that the reference groups of low flavonoid 
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intake may include individuals with higher levels of smoking. However, we controlled for 
various measures of smoking, including smoking status, duration of smoking, time since 
cessation and smoking intensity, incorporated into one parsimonious measure (i.e. the CSI)] (40). 
Only one previous study adjusted for time since quitting among former smokers (20), which is a 
factor that strongly impacts lung cancer risk (47, 48). We also had detailed information on other 
important potential confounders, including occupational carcinogens. 
 
The FFQ used in the study was designed to capture carotenoids and vitamin C, thus, did not 
include some flavonoid-rich items. For instance, onion, a major contributor to flavonols, was not 
assessed on our FFQ thus intake of the flavonol subclass was likely underestimated for all 
participants. Similarly, celery and parsley, major contributors to flavones (34) were not assessed 
thus leading to underestimation of flavone intake. Nonetheless, intake of flavonoid subclasses in 
our study was similar to previous studies that used the USDA flavonoids database (10, 16, 21, 
23).  Unfortunately, since soy, tofu and other isoflavone-rich foods, such as chickpeas and 
peanuts, were not included on our FFQ, we were not able to capture a large contrast in isoflavone 
intake in our study population, thus precluding a comprehensive analysis. However, our FFQ 
assessed citrus fruits, berries, tea and wine, which are the main contributors to flavanones, 
flavon-3-ols and anthocyanidins, and which are flavonoid subclasses not extensively examined 
previously. Indeed, tea, wine and beer are not major contributors to carotenoids and vitamin C, 
thus, our analysis of flavonoids captures a different aspect of diet than the analysis of carotenoids 
and vitamin C, or of alcohol or tea.   
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In summary, our results suggest that low flavonoid intake from food sources may increase the 
risk of lung cancer, particularly for squamous cell carcinoma.  While smoking remains the most 
important factor associated with lung cancer risk, the identification of other modifiable factors 
can offer additional avenues for lung cancer prevention.  
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Table 1. Characteristics of the study population, n (%) 
 Women Men 
 Cases N =399 
Controls 
N =574 
Cases 
N =662 
Controls 
N=851 
Age, years     
 <45  22 (5.5) 33 (5.8) 13 (2.0) 17 (2.0) 
 45-<55 73 (18.3) 115 (20.0) 71 (10.7) 83 (9.8) 
 55-<65  138 (34.6) 183 (31.9) 218 (32.9) 246 (28.9) 
 65+  166 (41.6) 243 (42.3) 360 (54.4) 505 (59.3) 
Respondent status     
 Self 272 (68.2) 548 (95.5) 416 (62.8) 771 (90.6) 
 Proxy 127 (31.8) 26 (4.5) 246 (37.2) 80 (9.4) 
Ethnic origin     
 French ancestry 315 (79.0) 397 (69.2)  516 (78.0) 545 (64.0) 
 Other 84 (21.0) 177 (30.8) 146 (22.0) 306 (36.0) 
BMI, kg/m2     
       Underweight (<18.5) 34 (8.5) 19 (3.3) 25 (3.8) 10 (1.2) 
       Normal weight (18.5-<25.0) 206 (51.6) 270 (47.0) 315 (47.6) 335 (39.4) 
       Overweight (25.0-<30.0) 112 (28.1)  205 (35.7) 242 (36.6) 394 (46.3) 
       Obese (30.0+) 47 (11.8) 80 (14.0) 80 (12.1) 112 (13.2) 
Mean census tract family income, 
$1     
 Low 189 (47.4) 192 (33.4) 258 (39.0) 288 (33.8) 
 Middle 135 (33.8) 191 (33.3) 211 (31.9) 280 (32.9) 
 High 75 (18.8) 191 (33.3) 193 (29.2) 283 (33.3) 
Education level, years     
 <7 85 (21.3) 95 (16.6) 186 (28.1) 212 (24.9) 
 7-<13 238 (59.7) 271 (47.2) 373 (56.3) 405 (47.6) 
 13+ 76 (19.0) 208 (36.2) 103 (15.6) 234 (27.5) 
Daily Alcoholic Drinks     
       Non-drinker 335 (84.0) 497 (86.6) 368 (55.6) 535 (62.9) 
       >0 to <2 standard drinks 30 (7.5) 54 (9.4) 56 (8.4) 81 (9.5) 
       2 + standard drinks 34 (8.5) 23 (4.0) 238 (36.0) 235 (27.6) 
Cigarette Smoking     
 Never 31 (7.8) 294 (51.2) 16 (2.4) 151 (17.7) 
 Former (quit 10+ years ago) 42 (10.5) 109 (19.0) 137 (20.7) 381 (44.8) 
 Former (quit 2-<10 years ago) 36 (9.0) 46 (8.0) 65 (9.8) 79 (9.3) 
 Current2 290 (72.7) 125 (21.8) 444 (67.1) 240 (28.2) 
Histological type     
 Adenocarcinoma 193 (48.4) -- 219 (33.1) -- 
 Squamous cell carcinoma 78 (19.6) -- 234 (35.4) -- 
 Small cell carcinoma 67 (16.8) -- 111 (16.8) -- 
 Large cell carcinoma 35 (8.8) -- 64 (9.7) -- 
 Other or unspecified 26 (6.5) -- 34 (5.1) -- 
1 Low, medium and high correspond to sex-specific tertiles based on the distribution among controls 
2 Current smokers include individuals that quit <2 years before recruitment 
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Table 2. Food and beverage items that primarily contributed to flavonoid intake in the 
study population 
 Primary contributors (percent contribution to intake)1 
 Food Beverage 
Total flavonoids Citrus fruits (8%) 
Apples/pears (4%) 
Berries (2%) 
Black tea (70%) 
Citrus juices (8%) 
Anthocyanidins Berries (46%) 
Apples/pears (22%) 
Red wine (22%) 
Flavan-3-ols Apples/pears (2%) Black tea (92%) 
Beer (2%) 
Red wine (2%) 
Flavones Citrus fruits (32%) 
Lettuce (12%) 
Watermelon (8%) 
Red wine (28%) 
 
Flavonols Apples/pears (16%) 
Lettuce (8%) 
Black tea (36%) 
Beer (12%) 
Flavanones Citrus fruits (62%) 
 
Citrus juices (34%) 
Red wine/white wine (2%) 
1 The denominator for the percent contribution includes total intake of the flavonoid subclass in the study population 
from both food and beverage 
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Table 3. Odds ratios (95% confidence intervals) of lung cancer for quartiles of flavonoid 
intake 
 Quartile of intake1 
 1 2 3 4 
Total flavonoids     
 #cases/#controls 396/355 172/357 175/356 318/357 
 OR (95% CI)2 1.00 0.43 (0.34-0.54) 0.51 (0.40-0.63) 0.83 (0.67-1.03) 
 OR (95% CI)3 1.00 0.64 (0.48-0.85) 0.76 (0.57-1.02) 0.94 (0.72-1.22) 
Anthocyanidins, total     
 #cases/#controls 451/357 236/356 182/357 192/355 
 OR (95% CI)2 1.00 0.52 (0.42-0.65) 0.40 (0.32-0.50) 0.43 (0.34-0.54) 
 OR (95% CI)3 1.00 0.97 (0.73-1.27) 0.70 (0.53-0.94) 0.87 (0.65-1.16) 
Flavan-3-ols, total     
   #cases/#controls 311/357 174/356 251/357 325/355 
 OR (95% CI)2 1.00 0.56 (0.44-0.71) 0.81 (0.65-1.01) 1.07 (0.86-1.33) 
 OR (95% CI)3 1.00 0.91 (0.67-1.22) 0.83 (0.61-1.13) 1.06 (0.81-1.39) 
Flavones, total     
   #cases/#controls 498/357 210/356 186/357 167/355 
 OR (95% CI)2 1.00 0.42 (0.34-0.53) 0.38 (0.30-0.47) 0.34 (0.27-0.43) 
 OR (95% CI)3 1.00 0.63 (0.48-0.84) 0.67 (0.51-0.89) 0.67 (0.50-0.91) 
Flavonols, total     
   #cases/#controls 329/357 212/356 201/357 319/355 
 OR (95% CI)2 1.00 0.65 (0.52-0.81) 0.61 (0.49-0.77) 0.99 (0.80-1.22) 
 OR (95% CI)3 1.00 0.76 (0.57-1.01) 0.66 (0.49-0.88) 0.98 (0.74-1.28) 
Flavanones, total     
 #cases/#controls 461/357 268/356 156/357 176/355 
 OR (95% CI)2 1.00 0.58 (0.47-0.72) 0.34 (0.27-0.43) 0.39 (0.31-0.49) 
 OR (95% CI)3 1.00 0.94 (0.71-1.23) 0.61 (0.45-0.82) 0.69 (0.52-0.93) 
1 Quartile cut points for total intake are based on flavonoid intake adjusted for total energy using the residual method and are as 
follows (in mg/day): Anthocyanidin: Female <8.0, 8.0-<10.8, 10.8-<15.4, 15.4+, Male <6.6, 6.6-<13.3, 13.3-<23.1, 23.1+; 
Flavan-3-ols: Female <8.7, 8.7-<14.8, 14.8-<249.1, 249.1+,  Male <12.6, 12.6-<24.8, 24.8-<271.0, 271.0+; Flavones: Female 
<0.6, 0.6-<0.9, 0.9-<1.4, 1.4+, Male <0.7, 0.7-<1.3, 1.3-<2.1, 2.1+; Flavonols: Female <7.6, 7.6-<11.0, 11.0-<16.6, 16.6+, Male: 
<11.7, 11.7-<16.7, 16.7-<24.3, 24.3+; Flavanones: Female <18.7, 18.7-<32.3, 32.3-<50.3, 50.3+, Male: <20.8, 20.8-<44.0, 44.0-
<64.6, 64.6+. 
2 ORs are adjusted for age and sex 
3 ORs are adjusted for age, sex, number of school years (<7, 7-<13, 13+), mean census tract family income (low, medium, high), 
ethnic group (French Canadian, other), respondent status (self, proxy), comprehensive smoking indicator (continuous),  
occupational exposure to carcinogens (none, ever), BMI (underweight, normal weight, overweight, obese), number of alcoholic 
drinks/day (continuous) and total energy intake (continuous) 
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Table 4. Adjusted odds ratios1 (95% confidence intervals) between lung cancer and total 
intake of flavonoids and flavonoid subclasses, stratified by sex and by smoking 
 Quartile of intake P (int)2 
 1 2 3 4  
By Sex      
 Total flavonoids      
  Male 1.00 0.68 (0.47-0.98) 0.73 (0.50-1.05) 1.01 (0.73-1.40)  
  Female 1.00 0.57 (0.34-0.95) 0.85 (0.52-1.42) 0.77 (0.48-1.22) 0.66 
 Anthocyanidins, total      
  Male 1.00 1.32 (0.94-1.87) 0.92 (0.64-1.31) 0.97 (0.66-1.44)  
  Female 1.00 0.55 (0.34-0.90) 0.43 (0.26-0.71) 0.74 (0.46-1.18) <0.01 
 Flavan-3-ols, total      
  Male 1.00 0.98 (0.67-1.43) 0.95 (0.64-1.41) 1.18 (0.84-1.67)  
  Female 1.00 0.80 (0.48-1.33) 0.75 (0.44-1.26) 0.85 (0.53-1.35) 0.60 
 Flavones, total      
  Male 1.00 0.65 (0.46-0.91) 0.61 (0.42-0.88) 0.67 (0.45-0.99)  
  Female 1.00 0.58 (0.35-0.96) 0.79 (0.49-1.28) 0.67 (0.41-1.11) 0.68 
 Flavonols, total      
  Male 1.00 0.79 (0.55-1.13) 0.67 (0.46-0.97) 1.14 (0.81-1.60)  
  Female 1.00 0.79 (0.48-1.30) 0.67 (0.41-1.11) 0.75 (0.47-1.20) 0.69 
 Flavanones, total      
  Male 1.00 0.98 (0.70-1.37) 0.60 (0.41-0.89) 0.67 (0.46-0.97)  
  Female 1.00 0.83 (0.52-1.35) 0.53 (0.32-0.89) 0.63 (0.39-1.03) 0.49 
By Smoking Level3      
 Total flavonoids      
  Never-light 1.00 0.60 (0.32-1.10) 1.12 (0.66-1.91) 0.74 (0.43-1.27)  
  Moderate-heavy 1.00 0.63 (0.45-0.89) 0.62 (0.44-0.89) 0.99 (0.73-1.34) 0.40 
 Anthocyanidins, total      
  Never-light 1.00 1.03 (0.58-1.82) 0.96 (0.54-1.72) 1.14 (0.65-1.99)  
  Moderate-heavy 1.00 0.96 (0.70-1.33) 0.65 (0.47-0.91) 0.77 (0.54-1.09) 0.97 
 Flavan-3-ols, total      
  Never-light 1.00 1.29 (0.73-2.29) 1.59 (0.86-2.92) 1.01 (0.56-1.81)  
  Moderate-heavy 1.00 0.80 (0.56-1.14) 0.69 (0.48-1.00) 1.08 (0.79-1.49) 0.46 
 Flavones, total      
  Never-light 1.00 0.54 (0.30-0.98) 0.68 (0.38-1.21) 0.84 (0.48-1.46)  
  Moderate-heavy 1.00 0.66 (0.47-0.91) 0.67 (0.48-0.93) 0.57 (0.40-0.82) 0.20 
 Flavonols, total      
  Never-light 1.00 1.26 (0.72-2.22) 1.26 (0.71-2.23) 0.93 (0.53-1.64)  
  Moderate-heavy 1.00 0.65 (0.46-0.91) 0.54 (0.38-0.77) 1.00 (0.72-1.38) 0.24 
 Flavanones, total      
  Never-light 1.00 0.76 (0.44-1.32) 0.57 (0.32-1.02) 0.58 (0.33-1.02)  
  Moderate-heavy 1.00 1.02 (0.74-1.41) 0.61 (0.43-0.87) 0.71 (0.50-1.01) 0.44 
1 ORs adjusted for the same variables indicated in footnote 3 of table 3 
2 P-value for the test for interaction; the test for interaction by smoking level used the comprehensive smoking indicator (CSI)  
3 Never-light smokers includes lifetime never smokers combined with people in the lowest quartile of the CSI among ever 
smokers (n=134 cases, 857 controls); Moderate-heavy smokers are those in the upper three quartile of the CSI among ever 
smokers (n=927 cases, 568 controls) 
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Table 5. Adjusted odds ratios1 (95% confidence intervals) between lung cancer and total 
intake of flavonoids and flavonoid subclasses, by dietary source of flavonoids 
 Quartile of intake 
 1 2 3 4 
Total flavonoids     
 Beverage sources only 1.00 0.97 (0.71-1.32) 1.12 (0.81-1.55) 1.19 (0.87-1.63) 
 Food sources only 1.00 0.64 (0.49-0.84) 0.62 (0.47-0.83) 0.63 (0.47-0.85) 
Anthocyanidins     
 Beverage sources only 1.00 0.96 (0.69-1.34) 1.10 (0.75-1.61) 1.10 (0.75-1.62) 
 Food sources only 1.00 1.05 (0.80-1.38) 0.81 (0.61-1.09) 0.82 (0.61-1.11) 
Flavan-3-ols     
 Beverage sources only 1.00 1.00 (0.73-1.37) 1.03 (0.74-1.44) 1.17 (0.85-1.59) 
 Food sources only 1.00 0.87 (0.66-1.15) 0.75 (0.56-1.01) 0.67 (0.50-0.90) 
Flavones     
 Beverage sources only 1.00 0.96 (0.69-1.34) 1.10 (0.75-1.61) 1.10 (0.75-1.62) 
 Food sources only 1.00 0.72 (0.54-0.94) 0.70 (0.52-0.93) 0.68 (0.50-0.93) 
Flavonols     
 Beverage sources only 1.00 0.99 (0.73-1.35) 1.00 (0.73-1.38) 1.13 (0.83-1.55) 
 Food sources only 1.00 0.89 (0.68-1.15) 0.64 (0.48-0.87) 0.62 (0.45-0.84) 
Flavanones     
 Beverage sources only 1.00 0.96 (0.69-1.34) 1.10 (0.75-1.61) 1.10 (0.75-1.62) 
 Food sources only 1.00 0.97 (0.74-1.27) 0.60 (0.44-0.81) 0.70 (0.53-0.94) 
1 ORs adjusted for the same variables indicated in footnote 3 of table 3 
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Table 6. Adjusted odds ratios1 (95% confidence intervals) between each of three histologic types2 of lung 
cancer and intake of flavonoids and flavonoid subclasses from all sources and food sources only 
 Quartile of intake P (het)3  1 2 3 4 
Total flavonoids, all sources      
 Adenocarcinoma 1.00 0.75 (0.52-1.08) 0.87 (0.60-1.26) 1.09 (0.78-1.51)  
 Squamous cell carcinoma 1.00 0.55 (0.36-0.85) 0.60 (0.39-0.92) 0.92 (0.65-1.30)  
 Small cell carcinoma 1.00 0.53 (0.30-0.92) 1.00 (0.60-1.68) 0.80 (0.50-1.25) 0.12 
Anthocyanidins, all sources      
 Adenocarcinoma 1.00 1.04 (0.74-1.47) 0.74 (0.52-1.07) 0.93 (0.65-1.34)  
 Squamous cell carcinoma 1.00 0.89 (0.61-1.30) 0.59 (0.39-0.89) 0.75 (0.49-1.13)  
 Small cell carcinoma 1.00 0.99 (0.61-1.61) 0.77 (0.47-1.28) 1.01 (0.59-1.73) 0.76 
Flavan-3-ols, all sources      
 Adenocarcinoma 1.00 1.15 (0.79-1.69) 1.02 (0.69-1.52) 1.35 (0.95-1.90)  
 Squamous cell carcinoma 1.00 0.73 (0.47-1.13) 0.67 (0.43-1.04) 0.98 (0.68-1.41)  
 Small cell carcinoma 1.00 0.74 (0.43-1.28) 0.65 (0.37-1.14) 0.78 (0.49-1.25) 0.22 
Flavones, all sources      
 Adenocarcinoma 1.00 0.72 (0.50-1.02) 0.84 (0.59-1.20) 0.86 (0.59-1.25)  
 Squamous cell carcinoma 1.00 0.59 (0.40-0.85) 0.42 (0.27-0.65) 0.48 (0.31-0.75)  
 Small cell carcinoma 1.00 0.54 (0.33-0.89) 0.72 (0.43-1.19) 0.65 (0.36-1.15) <0.01 
Flavonols, all sources      
 Adenocarcinoma 1.00 0.88 (0.61-1.28) 0.87 (0.60-1.26) 1.18 (0.83-1.67)  
 Squamous cell carcinoma 1.00 0.69 (0.46-1.04) 0.46 (0.30-0.71) 0.93 (0.65-1.35)  
 Small cell carcinoma 1.00 0.67 (0.40-1.11) 0.56 (0.32-0.96) 0.75 (0.47-1.21) 0.08 
Flavanones, all sources      
 Adenocarcinoma 1.00 0.92 (0.65-1.30) 0.68 (0.47-1.00) 0.89 (0.62-1.27)  
 Squamous cell carcinoma 1.00 0.74 (0.51-1.07) 0.54 (0.35-0.82) 0.48 (0.32-0.74)  
 Small cell carcinoma 1.00 1.20 (0.76-1.91) 0.51 (0.28-0.93) 0.70 (0.41-1.20) 0.02 
 
Total flavonoids, food sources      
 Adenocarcinoma 1.00 0.69 (0.48-0.97) 0.86 (0.60-1.22) 0.78 (0.53-1.14)  
 Squamous cell carcinoma 1.00 0.56 (0.39-0.82) 0.53 (0.35-0.81) 0.43 (0.27-0.68)  
 Small cell carcinoma 1.00 0.73 (0.46-1.15) 0.44 (0.25-0.79) 0.60 (0.34-1.07) <0.01 
Anthocyanidins, food sources      
 Adenocarcinoma 1.00 1.10 (0.78-1.56) 0.94 (0.66-1.35) 0.89 (0.61-1.30)  
 Squamous cell carcinoma 1.00 1.11 (0.77-1.60) 0.69 (0.46-1.04) 0.68 (0.44-1.06)  
 Small cell carcinoma 1.00 1.03 (0.63-1.66) 0.67 (0.39-1.14) 1.09 (0.65-1.85) 0.36 
Flavan-3-ols, food sources      
 Adenocarcinoma 1.00 0.86 (0.61-1.22) 0.82 (0.57-1.17) 0.77 (0.53-1.13)  
 Squamous cell carcinoma 1.00 0.92 (0.63-1.33) 0.66 (0.43-1.00) 0.58 (0.38-0.89)  
 Small cell carcinoma 1.00 0.95 (0.59-1.55) 0.85 (0.50-1.44) 0.73 (0.42-1.27) 0.52 
Flavones, food sources      
 Adenocarcinoma 1.00 0.82 (0.57-1.16) 0.88 (0.62-1.26) 0.82 (0.56-1.21)  
 Squamous cell carcinoma 1.00 0.70 (0.49-1.02) 0.41 (0.27-0.64) 0.51 (0.33-0.80)  
 Small cell carcinoma 1.00 0.69 (0.42-1.12) 0.72 (0.43-1.20) 0.52 (0.28-0.97) <0.01 
Flavonols, food sources      
 Adenocarcinoma 1.00 0.91 (0.65-1.26) 0.85 (0.58-1.23) 0.70 (0.47-1.04)  
 Squamous cell carcinoma 1.00 0.82 (0.57-1.17) 0.50 (0.32-0.79) 0.50 (0.32-0.79)  
 Small cell carcinoma 1.00 0.83 (0.53-1.30) 0.56 (0.32-0.99) 0.49 (0.27-0.92) 0.08 
Flavanones, food sources      
 Adenocarcinoma 1.00 0.92 (0.65-1.30) 0.68 (0.47-1.00) 0.88 (0.61-1.27)  
 Squamous cell carcinoma 1.00 0.80 (0.55-1.16) 0.50 (0.32-0.77) 0.51 (0.33-0.77)  
 Small cell carcinoma 1.00 1.24 (0.78-1.96) 0.51 (0.28-0.91) 0.67 (0.39-1.17) 0.03 
1 ORs adjusted for the same variables indicated in footnote 3 of table 3 
2 n=412 cases of adenocarcinoma, 312 cases of squamous cell carcinoma and 178 cases of small cell carcinoma  
3 p-value for the likelihood ratio test of homogeneity of the ORs across histological types, which compared the deviance of two 
polytomous logistic models; the first, un-restricted model used 9 degree-of-freedom (df; 3 histologic type-specific parameters for 
each of the 3 higher quartiles) while the restricted, second model used only 3 df's (1 common parameter for each quartile), 
resulting in a 6-df difference for the likelihood ratio test 
